TKO Group Holdings posted a mixed earnings report after the bell Thursday, as revenue came in well above estimates but profit ...

The Neutrogena and Aveeno owner has also increased its 2025 full-year outlook to reflect the impact of costs associated with ...

ConocoPhillips CFO to retire after 39 years with the company, Kenvue and Mattel name new finance chiefs and Vodafone’s CFO to ...

Kenvue, Inc. (($KVUE)) has held its Q1 earnings call. Read on for the main highlights of the call. Kenvue’s recent earnings call revealed a mixed ...

Self care segment revenue growth updated Consumer health company Kenvue Inc. (NYSE:KVUE) on Thursday reported first-quarter ...

Kenvue beat Q1 sales estimates and updated its 2025 forecast as it manages foreign exchange impacts, tariffs, and leadership ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, ...

Amit Banati, 56, will succeed CFO Paul Ruh at Summit, New Jersey-based Kenvue, formerly the consumer healthcare division of ...

We believe Kenvue is in fine financial health. The firm ended 2024 with about $1.1 billion in cash and $8.6 billion in debt. Despite the large debt balance compared with its current level of cash, we ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the ...

Shares of Kenvue rose in premarket trading Thursday after the maker of Band-Aid, Tylenol, and Listerine reported ...